Epidemiology of human influenza A and B viruses in myanmar from 2005 to 2007

Intervirology

Volumn 52, Issue 6, 2009, Pages 310-320

  Dapat, Clyde ^a   Saito, Reiko ^a   Kyaw, Yadanar ^b   Naito, Makoto ^a   Hasegawa, Go ^a   Suzuki, Yasushi ^a   Dapat, Isolde C ^a   Zaraket, Hassan ^a   Cho, Tin Maung ^c   Li, Danjuan ^a   Oguma, Taeko ^a   Baranovich, Tatiana ^a   Suzuki, Hiroshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Sanpya Hospital   (Myanmar)

^c Yangon General Hospital   (Myanmar)

Author keywords

Amantadine resistant influenza A viruses; Human influenza A and B viruses, epidemiology; Influenza A H1N1 viruses; Influenza A H3N2 Isolates; Influenza B viruses; Influenza surveillance, Myanmar; Sentinel influenza surveillance sites

Indexed keywords

AMANTADINE; PROTEIN M2;

ARTICLE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; HA GENE; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MYANMAR; NA GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; SEASONAL VARIATION; VIRUS GENE; VIRUS ISOLATION; VIRUS RESISTANCE;

AMANTADINE; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; MYANMAR; NEURAMINIDASE; PHYLOGENY; RNA, VIRAL; SEASONS; SEQUENCE ANALYSIS, RNA;

CERCOPITHECINE HERPESVIRUS 1; INFLUENZA A VIRUS; INFLUENZA B VIRUS;

EID: 70349264256     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000237738     Document Type: Article

References (43)

1. Escuret V, Frobert E, Bouscambert-Duchamp M, et al: Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors. J Clin Virol 2008; 41: 25-28.
2. Suzuki H, Saito R, Masuda H, et al: Emergence of amantadine-resistant influenza A viruses: epidemiological study. J Infect Chemother 2003; 9: 195-200.
3. Gachara G, Ngeranwa J, Magana JM, et al: Influenza virus strains in Nairobi, Kenya. J Clin Virol 2006; 35: 117-118.
4. Hasegawa G, Kyaw Y, New HM, et al: Epidemiological study of influenza virus infections in Yangon, Myanmar. Trop Med Health 2006; 34: 3-6.
5. Viboud C, Alonso WJ, Simonsen L: Influenza in tropical regions. PLoS Med 2006; 3: 468-471.
6. Russell CA, Jones TC, Barr IG, et al: The global circulation of seasonal influenza A (H3N2) viruses. Science 2008; 320: 340-346.
7. Li D, Saito R, Le MTQ, et al: Genetic analysis of influenza A/H3N2 and A/H1N1 viruses circulating in Vietnam from 2001 to 2006. J Clin Microbiol 2008; 46: 399-405.
8. Bright RA, Medina MJ, Xu X, et al: Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005; 366: 1175-1181.
9. Barr IG, Hurt AC, Iannello P, et al: Increased amantadine resistance in influenza A (H3) viruses in Australia and neighboring countries in 2005. Antiviral Res 2007; 73: 112-117.
10. Saito R, Li D, Suzuki H: Amantadine-resistant influenza A (H3N2) virus in Japan, 2005-2006. N Engl J Med 2007; 356: 312-313. (Pubitemid 46143250)
11. Bright RA, Shay DK, Shu B, et al: Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006; 295: 891-894.
12. Hasegawa G, Kyaw Y, Li D, et al: Influenza virus infections in Yangon, Myanmar. J Clin Virol 2006; 37: 233-234.
13. Center for Disease Control: Concepts and Procedures for Laboratory-Based Influenza Surveillance. Atlanta, US Department of Health, Public Health Service, 1982.
14. Hoffmann E, Stech J, Guan Y, et al: Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 2001; 146: 2275-2289.
15. Burland TG: DNASTAR's Lasergene sequence analysis software. Methods Mol Biol 2000; 132: 71-91.
16. Tamura K, Dudley J, Nei M, et al: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-1599.
17. Hay AJ, Wolstenholme AJ, Skehel JJ, et al: The molecular basis of the specific anti-influenza action of amantadine. EMBO J 1985; 4: 3021-3024.
18. Schnell JR, Chou JJ: Structure and mechanism of the M2 proton channel of influenza A virus. Nature 2008; 451: 591-595.
19. WHO: Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season. Wkly Epidemiol Rec 2005; 80: 65-76.
20. WHO: Recommended composition of influenza virus vaccines for use in the 2007-2008 influenza season. Wkly Epidemiol Rec 2007; 82: 69-74.
21. Rambaut A, Pybus OG, Nelson MI, et al: The genomic and epidemiological dynamics of human influenza A virus. Nature 2008; 453: 615-619.
22. Shek LP, Lee BW: Epidemiology and seasonality of respiratory tract virus infections in the tropics. Paediatr Respir Rev 2003; 4: 105-111.
23. Simmerman JM, Thawatsuoha P, Kingnate D, et al: Influenza in Thailand: a case study for middle income countries. Vaccine 2004; 23: 182-187.
24. Nguyen HLK, Saito R, Ngiem HK, et al: Epidemiology of influenza in Hanoi, Vietnam, 2001-2003. J Infect 2007; 55: 58-63.
25. Tsai HP, Kuo PH, Liu CC, et al: Respiratory viral infections among pediatric inpatients and outpatients in Taiwan from 1997 to 1999. J Clin Microbiol 2001; 39: 111-118.
26. WHO: Summary of influenza activity, September 2004-August 2005. Wkly Epidemiol Rec 2005; 80: 353-360.
27. WHO: Influenza in the world, September 2006-August 2007. Wkly Epidemiol Rec 2007; 82: 357-360.
28. Saito R, Suzuki Y, Li D, et al: Increased incidence of adamantine-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan. J Infect Dis 2008; 197: 630-632.
29. Zaraket H, Dbaibo G, Salam O, et al: Influenza virus infections in Lebanese children in the 2007-2008 season. Jpn J Infect Dis 2009; 62: 137-138.
30. Reyes F, Aziz S, Winchester B, et al: Influenza in Canada: 2007-2008 season update. Can Commun Dis Rep 2008; 34: 1-9.
31. CDC: Influenza activity - United States and worldwide, 2007-2008 season. MMWR 2008; 57: 692-697.
32. Barr IG, Deng YM, Iannello P, et al: Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries. Antiviral Res 2008; 80: 200-205.
33. WHO: Recommended composition of influenza virus vaccines for use in the 2008-2009 influenza season. Wkly Epidemiol Rec 2008; 83: 77-88.
34. Saito R, Li D, Suzuki Y, et al: High prevalence of amantadine-resistance influenza A (H3N2) in six prefectures, Japan, in the 2005-2006 season. J Med Virol 2007; 79: 1569-1576.
35. Hay AJ, Gregory V, Douglas AR, et al: The evolution of human influenza viruses. Phil Trans R Soc Lond B 2001; 356: 1861-1870.
36. Berton MT, Naeve CW, Webster RG: Antigenic structure of the influenza B virus hemagglutinin: nucleotide sequence analysis of antigenic variants selected with monoclonal antibodies. J Virol 1984; 52: 919-927.
37. Lin YP, Gregory V, Bennett H, et al: Genetic reassortment among recently circulating human influenza A and B viruses. Int Congr Ser 2004; 1263: 178-183.
38. Shaw MW, Xu X, Li Y, et al: Reappearance and global spread of variants of influenza B/ Victoria/2/87 lineage viruses in the 2000- 2001 and 2001-2002 seasons. Virology 2002; 303: 1-8.
39. Jian JW, Lai CT, Kuo CY, et al: Genetic analysis and evaluation of the reassortment of influenza B viruses isolated in Taiwan during the 2004-2006 and 2006-2007 epidemics. Virus Res 2008; 131: 243-249.
40. Lin JH, Chiu SC, Shaw MW, et al: Characterization of the epidemic influenza B viruses isolated during 2004-2005 season in Taiwan. Virus Res 2007; 124: 204-211.
41. Chen R, Holmes EC: The evolutionary dynamics of human influenza B virus. J Mol Evol 2008; 66: 655-663.
42. Besselar TG, Botha L, McAnerney JM, et al: Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localized influenza outbreak in South Africa in 2003. J Med Virol 2004; 73: 71-78.
43. Nakagawa N, Kubota R, Maeda A, et al: Heterogeneity of influenza B virus strains in one epidemic season differentiated by monoclonal antibodies and nucleotide sequences. J Clin Microbiol 2000; 38: 3467-3469.